TerSera Therapeutics has a total of 107 patents globally, out of which 86 have been granted. Of these 107 patents, more than 84% patents are active. The United States of America is where TerSera Therapeutics has filed the maximum number of patents, followed by Germany and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of TerSera Therapeutics.
TerSera Therapeutics was founded in 2016. TerSera Therapeutics is a company that specializes in pharmaceuticals. The company’s area of expertise is creating and purchasing specialist pharmaceutical products, with a particular emphasis on particular therapeutic areas.
Do read about some of the most popular patents of TerSera Therapeutics which have been covered by us in this article and also you can find TerSera Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over TerSera Therapeutics patent portfolio.
How many patents does TerSera Therapeutics have?
TerSera Therapeutics has a total of 107 patents globally. These patents belong to 17 unique patent families. Out of 107 patents, 90 patents are active.
How Many Patents did TerSera Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | TerSera Therapeutics Applications Filed | TerSera Therapeutics Patents Granted |
| 2023 | 2 | – |
| 2022 | – | 4 |
| 2021 | 3 | 5 |
| 2020 | – | 13 |
| 2019 | 2 | 1 |
| 2018 | – | 4 |
| 2017 | 1 | 4 |
| 2016 | – | 4 |
| 2015 | 1 | 1 |
| 2014 | 1 | 7 |
| 2013 | 2 | 8 |
| 2012 | 14 | 9 |
| 2011 | 7 | 9 |
Explore the top-performing drugs that dominate the Pharmaceutical Industry
| Patent Number | Company | Product | Brand | Revenue | Patent Expiry Date |
| US9174975 | Sumitomo Pharma | Lurasidone Hydrochloride | Latuda | $1.75B | Jun-26 |
| US7612199 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7902206 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US8158644 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7371727 | Ironwood Pharma | Linaclotide | Linzess | $1.00B | Mar-25 |
Want to know which drugs are making over $1 Billion annually?
How many TerSera Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did TerSera Therapeutics File in Different Countries?
Countries in which TerSera Therapeutics Filed Patents
| Country | Patent |
| United States Of America | 37 |
| Germany | 9 |
| Canada | 8 |
| Israel | 7 |
| New Zealand | 6 |
| Brazil | 5 |
| Austria | 5 |
| Australia | 5 |
| Europe | 5 |
| Norway | 4 |
| South Africa | 4 |
| Singapore | 3 |
| Italy | 3 |
| Spain | 3 |
| Hungary | 1 |
Where are Research Centers of TerSera Therapeutics Patents Located?
10 Best TerSera Therapeutics Patents
US7118552B2 is the most popular patent in the TerSera Therapeutics portfolio. It has received 179 citations so far from companies like Oracle, Safeshot Technologies, The Medical House Limited.
Below is the list of 10 most cited patents of TerSera Therapeutics:
| Publication Number | Citation Count |
| US7118552B2 | 179 |
| US7500964B2 | 108 |
| US7220247B2 | 102 |
| US7524812B2 | 64 |
| US7553840B2 | 57 |
| US7709493B2 | 40 |
| US7723345B2 | 24 |
| US7268109B2 | 20 |
| US8268774B2 | 16 |
| US7977307B2 | 13 |
What are TerSera Therapeutics key innovation segments?
What Technologies are Covered by TerSera Therapeutics?
The chart below distributes patents filed by TerSera Therapeutics